Shinhan Private Equity logo

Shinhan Private Equity

Asia, Seoul-t'ukpyolsi, South Korea, Seoul

Description

Shinhan Private Equity, Co,. Ltd. was established as an independent subsidiary company of Shinhan Financial Group in Dec. 2004 to

Investor Profile

Shinhan Private Equity has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (33%)
  • Series C (33%)
  • Private Equity (33%)

Country Focus

  • United States (67%)
  • Singapore (33%)

Industry Focus

  • Biotechnology
  • Medical
  • Oncology
  • Therapeutics
  • Business Development
  • Cloud Computing
  • Cloud Security
  • Information Technology
  • Internet
  • Security
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Shinhan Private Equity frequently co-invest with?

MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 1
Celgene
North America, New Jersey, United States, Summit
Co-Investments: 1
IMM Investment
Asia, Cholla-namdo, South Korea, Kangnam
Co-Investments: 2
CH
North America, New York, United States, New York
Co-Investments: 1
QUAD Investment Management
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
Deerfield
North America, New York, United States, New York
Co-Investments: 1
Astellas Venture Management
North America, California, United States, Menlo Park
Co-Investments: 1
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 1
AB
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 1
Sphera Funds Management
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 1

What are some of recent deals done by Shinhan Private Equity?

Vedanta Biosciences

Cambridge, Massachusetts, United States

Vedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.

BiotechnologyBusiness DevelopmentMedical
Series CSep 23, 2019
Amount Raised: $16,600,000
Oncorus

Cambridge, Massachusetts, United States

Oncorus is an immuno-oncology company developing oncolytic viruses to fight cancer.

BiotechnologyMedicalOncologyTherapeutics
Series BAug 21, 2019
Amount Raised: $79,500,000
CDNetworks

Singapore, Central Region, Singapore

CDNetworks offers various solutions such as CDN, media delivery, cloud security, zero trust security, etc.

Cloud ComputingCloud SecurityInformation TechnologyInternetSecurityVideo on DemandVideo StreamingWeb Hosting
Private EquityDec 1, 2007
Amount Raised: $96,500,000